Arcturus Could Find Its COVID-19 Vaccine Limited To Smaller Markets

The company plans to seek an EUA in Vietnam for ARCT-154, but some analysts have questioned its prospects in major markets like the US.

Coronavirus globe
Arcturus announced Phase II/III data for its self-amplifying mRNA-based COVID-19 vaccine • Source: Shutterstock: ImageFlow

More from Archive

More from Scrip